goodpods headphones icon

To access all our features

Open the Goodpods app
Close icon

Deep Tech: From Lab to Market with Benjamin Joffe

Benjamin Joffe

Focus: In this podcast, founders and Investors share how science-based innovation can go to market -- from clean meat to service robots. It is hosted by Benjamin Joffe, Partner at SOSV, a global early stage fund focused on deep tech. It invests first via its vertical accelerator programs including HAX (intelligent hardware) and IndieBio (biology). SOSV has over 1,000 startups in portfolio and manages over $700M. Keywords: #Technology #Deeptech #Venturecapital #Ventures #vc #robotics #lifesciences #biology #iot #internetofthings #hardware #startups #innovation #technology #accelerators #frontiertech #hardtech
share icon
not bookmarked icon

All episodes

Best episodes

Top 10 Deep Tech: From Lab to Market with Benjamin Joffe Episodes

Best episodes ranked by Goodpods Users most listened

episode art

The State and Opportunities In Robotics, with Fady Saad of MassRobotics

Deep Tech: From Lab to Market with Benjamin Joffe

play

08/31/20 • 42 min

MassRobotics helps startups commercialize innovations in robotics. Its ecosystem includes 350 startups, 40 corporates and over 100 VCs, PEs and LPs they advise. In this episode, Fady Saad talks about trends, acquisitions, failures and what has changed over the past decade in robotics. It is a little crash course on the robotics market.

This podcast is hosted by Benjamin Joffe (@benjaminjoffe), Partner at SOSV, a global early stage fund focused on deep tech. SOSV runs multiple accelerator programs including HAX (intelligent hardware) and IndieBio (life sciences).

To hear about new episodes, sign up to the newsletter or follow us on twitter at @LabToMarket or @SOSV.

OVERVIEW

Robotics often conjures images of giant factories or sci-fi dystopias. But what is the reality beyond the hype and fear?

Fady Saad is a former engineer who got exposed to cutting edge technologies of DARPA, NASA, the NSF and the AirForce. He grew a passion for robotics and founded MassRobotics in Boston as a robotics ‘escalator’ to help companies commercialize their innovations.

  • It is now a cluster of 350 robotics companies, 50 resident startups and 40 strategic partners.
  • They advise 150 VC firms, as well as investment banks, PE funds and corporates like GM and Lockheed Martin.

In this conversation, the most important takeaway is that robotics today is vastly different from 10 years ago. We also discuss:

  • The nature of robots,
  • The power of complex systems and emerging properties,
  • The difficulty of finding viable business applications,
  • Why we have a Roomba instead of a two-armed Rosey,
  • Trends, Acquisitions (over $8 billion in 2019), Failures,
  • The legacy of Willow Garage,
  • How to apply lean startup to robotics,
  • What successful companies do beyond tech skills and raising capital.

For other episodes covering robotics, listen to our podcasts with Robert Gallenberger (btov Partners), Kelly Chen (DCVC) and John Ho (Anzu Partners).

RECENT EPISODES

14. How Khosla Ventures Invests In Deep Tech — Kanu Gulati and Rajesh Swaminathan

13. Phil Morle (Main Sequence Ventures) on Australia's Deep Tech Ambitions

12. Habib Haddad and Calvin Chin (E14 Fund of MIT Media Lab) on Funding Science Fiction That Works

11. Robert Gallenberger (btov Partners) on How to Select Industrial Partners

RESOURCES ON DEEP TECH

bookmark
plus icon
share episode
episode art
play

08/23/20 • 37 min

Khosla Ventures (KV) has been an active investor in deep tech for 15 years. In this episode they share ideas on how they select sectors to invest in and prioritize and retire risk, how to best support startups, and what investors need to enter the deep tech field (hint: it's not a PhD).

This podcast is hosted by Benjamin Joffe, Partner at SOSV, a global early stage fund focused on deep tech. SOSV runs multiple accelerator programs including HAX (intelligent hardware) and IndieBio (life sciences). To hear about new episodes, sign up to the newsletter or follow us on twitter at @LabToMarket.

OVERVIEW

Kanu Gulati and Rajesh Swaminathan are Investment Partners focused on deep tech at Khosla Ventures. The firm was founded by Vinod Khosla -- co-founder of Sun Microsystems (acquired by Oracle for US$7.4 billion in 2009) and former General Partner at Kleiner Perkins -- with the goal of ‘Reinventing Social Infrastructure with Technology’, to elevate the entire planet’s quality of life without destroying it.

  • Over the past 15 years, KV has raised over $5B across 6 funds and invested in about 400 startups including Impossible Foods, Rocket Lab, DoorDash, OpenAI and many more.
  • They invest mostly at early stage — signing checks ranging from a few hundred $k, up to $50 million — and without shying away from the high technical risk of deep tech.

After an introduction and examples from KV’s portfolio, the conversation goes into:

  • Why it is crucial to prioritize risks and retire them in the right order.
  • The 12 different technologies that can move the needle for the climate crisis.
  • Their approach to detecting startups from centers of excellence.
  • What sectors KV focuses on, including climate tech, hyperlocal and bio-manufacturing, hardware acceleration for AI, and more.
  • What investment and operating partners do.
  • How they support their portfolio in particular with recruiting (white paper). Vinod Khosla even calls himself a ‘glorified recruiter’!
  • How conviction, immersion, patience and staying power matter more than a PhD to start investing in deep tech.
  • How more engagement between financial and corporate VCs, building more forums and reducing inefficiencies in the deep tech ecosystem could help.

PREVIOUS EPISODES

bookmark
plus icon
share episode

Getting innovation from lab to market is not an easy feat, and few countries do it well. Australia’s research output, for instance, punches way above its commercial applications (e.g. #10 in the SJR ranking and Nature Index).

Are there ways to accelerate that transformation? Australia set up Main Sequence Ventures (@mseqvc) as a AU$240M (about US$170M) deep tech fund backed by the CSIRO and private investors, to target that opportunity notably in domains such as ag-tech, synthetic biology, quantum and space (the CSIRO is the Australia’s federal government agency responsible for scientific research).

This podcast is hosted by Benjamin Joffe, Partner at SOSV, a global early stage fund focused on deep tech. SOSV runs multiple accelerator programs including HAX (intelligent hardware) and IndieBio (life sciences). To hear about new episodes, sign up to the newsletter or follow us on twitter at @LabToMarket.

For other episodes on foreign deep tech ecosystems, check out India and Japan.

OVERVIEW

In this episode, Phil Morle (@philmorle), partner and long-time pioneer of the country’s startup scene (wikipedia), explains the commonalities he found between entrepreneurs and scientists, how the fund extended its investment domains and helps compress development timelines.

He closes with thoughts on the tough year it has been with fires, drought and Covid, and how returns and impact now go hand in hand, from responding to new threats, feeding the planet, to delivering healthcare at scale.

Before Main Sequence Ventures, Phil had three lives:

  • He spent a decade as a theatre director, learning how to create things from scratch.
  • Another decade with startups including as CTO of Kazaa — the then-dominant P2P file-sharing service,
  • And another as the founder of Australia’s first Silicon Valley-style startup incubator, called Pollenizer, where he also advised numerous organizations including the CSIRO (Commonwealth Scientific and Industrial Research Organisation) on setting up their own incubators.
  • He was then tapped by the CSIRO to set up a fund to support the translation of Australian research into commercial applications, including the output of CSIRO’s 3,500 scientists.

Among the lessons learned:

  • How he got scientists to grow an entrepreneurial mindset.
  • How to look for early proof points for the whole company.
  • How spending too long in the science exclusively sends weak signals into the market.
  • How deal creation is more valuable than mere deal assessment and de-risking.
  • How they designed a plant-based meat company, assembled a team, and got a product to market in 9 months only.
  • How bridge-building between scientific domains, business expertise and geographies is crucial to startup success.
  • How Covid-19 has lit a fire in the innovation ecosystem.

PREVIOUS EPISODES

bookmark
plus icon
share episode

Habib Haddad and Calvin Chin are the Managing Partners of the E14 Fund, an early stage deep tech fund that invests exclusively in startups from the prolifically inventive MIT Media Lab community.

This podcast is hosted by Benjamin Joffe, Partner at SOSV, a global early stage fund focused on deep tech. SOSV runs multiple accelerator programs including HAX (intelligent hardware) and IndieBio (life sciences). To hear about new episodes, sign up to the newsletter or follow us on twitter at @LabToMarket.

For another episode covering Boston & Cambridge’s deep tech ecosystem, check out John Ho (Anzu Partners) on Breakthrough Industrial Tech.

INTRODUCTION

There is a bit of mystery shrouding the MIT Media Lab. If you’ve watched the movies Minority Report or Disney’s Big Hero 6, if you’ve used a touch screen, an e-reader, AR/VR devices, or played the game Guitar Hero, you’ve been touched by innovations from the Media Lab and its alumni.

The Media Lab is especially renowned for its interdisciplinary research. Its departments have names such as molecular machines, synthetic neurobiology or tangible media (if you stick until the end of the podcast, you will hear about a very curious project mixing wearable computing, emotions sensors and video).

In this episode, Habib and Calvin describe:

  • The journey that brought them to create the E14 Fund in 2013 (and why it’s named this way).
  • The importance of the community built around the Media Lab and the fund.
  • How they work with founders, supporting them sometimes years before it’s a startup ready for investment,
  • What differentiates the best founders from others,
  • What simple question you can ask founders to determine their ability to navigate both the short and long term,
  • How deep tech startups can be both less capital intensive, and more capital efficient than many think,
  • Why attracting, training and keeping foreign scientific talent in the US matters,
  • We end with some ideas on how to grow the investment in deep tech, and why this sector inevitably matter a great deal.

REFERENCES MENTIONED

PREVIOUS EPISODES

bookmark
plus icon
share episode
episode art
play

07/20/20 • 34 min

Few VC funds focus on deep tech in industry , and few investors have a strong industrial background. Robert Gallenberger at btov Partners is one of those rare people. He invests across Europe where he sees an industrial renaissance based on the combination of fresh tech talent with industry veterans , and making use of the strong industrial base particularly in Germany, Switzerland and more.

This podcast is hosted by Benjamin Joffe, Partner at SOSV, a global early stage fund focused on deep tech. SOSV runs multiple accelerator programs including HAX (intelligent hardware) and IndieBio (life sciences). To hear about new episodes, sign up to the newsletter or follow us on twitter at @LabToMarket.

For other episodes covering industrial investments, check out Kelly Chen (DCVC) on Investing in Old School Industries and John Ho (Anzu Partners) on Breakthrough Industrial Tech.

ABOUT ROBERT AND BTOV

Robert Gallenberger loves industrial technologies.

  • A former BMW engineer, MBA from London Business School and BCG consultant, he became a VC over a decade ago, and has mostly focused on industry startups ever since.
  • He is now a Partner in charge of the €100M Industrial Technologies Fund at btov (Twitter: btovPartners), an early stage European VC firm managing over €500M.

Founded 20 years ago as 'brains to ventures', and early investors in deep tech companies such as Volocopter (raised €118.2M) and OrCam (raised $86.4M), btov also built a network of 250 Private Investors to support their portfolio.

In this episode, Robert talks about:

  • His transition from industry to investment,
  • His vision on the opportunities in the sector (including 3D printing and the reinvention of supply chains in a post-covid world).

He also shares:

  • His approach to investment in industry 4.0,
  • Practical insights on how startups can avoid wasting time with the wrong industrial partners,
  • What could be done to grow the ecosystem.

PREVIOUS EPISODES

bookmark
plus icon
share episode

First, let’s state that I have been a fan of Xavier since I was first invited to speak about hardware startups at his Hello Tomorrow Global Summit in 2016. Hello Tomorrow is a #deeptech community, and its Summit is the largest deep tech event in the world, featuring yearly 500 global startups.

I was impressed by the production quality and general vibe; I’ve attended every year since then, and it only got better (trivia: on that day, I also remember meeting another man who talked about embracing tech entrepreneurship. He shook everyone’s hand on his way to the stage, where he was speaking right before me. Can you guess who that was?).

ABOUT XAVIER AND HELLO TOMORROW

Now, Xavier Duportet turned out to be more than the founder of what is probably the world’s largest deep tech event. He’s also a synthetic biology PhD with an unusual path:

  • He was born in France, grew a passion for insects (especially ants — he hosts a colony of leaf-cutter ants from Trinidad in his office) that lead him to an internship in a genetics lab at age 12, which ignited his passion for science.
  • Fast forward a few years, after a first startup attempt, he earned his PhD across multiple labs including a stay at MIT which had a profound effect on his mindset and understanding of ecosystems.
  • He came back to France and became a catalyst in the emerging deep tech community by founding in 2011 a non-profit called Hello Tomorrow to bring together scientists, investors and corporates. Today, the event is — afaik — the largest deep tech conference in the world and highlights every year 500 of the top early stage startups. The next summit will take place in Paris and online in October 2020.
  • In 2018, he co-founded Deeptech Founders, a 6-months program that already helped hundreds of global scientists and engineers to accelerate their startup projects.
  • Today, he is the founder of Eligo Bioscience, a biotech startup using CRISPR to create a new class of biotherapeutic agents to selectively intervene on the microbiome. Eligo raised $27.4M from French and US investors including Khosla Ventures and Seventure Partners.
  • Finally, Xavier has been selected as a World Economic Forum Pioneer and Young Global Leader, as well as one of the top innovators under 35 by MIT.

OVERVIEW

  • In this episode, Xavier shares ideas about science entrepreneurship and the importance of a product-driven mindset.
  • We also discuss how co-founders need be complementary, and combine technology with storytelling and networks to succeed.
  • Finally, he shares his hopes about deep tech’s ability to solve critical problems that digital alone can’t solve, and the importance of accessible role models to support this mission (his historical role model could be called ‘the Edison of biology’ — here is one of his key patents).

REFERENCES MENTIONED

  • Eligo Bioscience, Xavier’s startup developing new therapies for the microbiome.
  • Deeptech Founders, a training program for global founders.
  • Hello Tomorrow, organizers of the largest deep tech event in the world.
  • Tim Lu, Associate Professor of Biological Engineering and Electrical Engineering and Computer Science at MIT
  • The Story of Louis Pasteur. A documentary from 1936 on this unique science entrepreneur.
  • A brief history of Genentech, the first publicly-owned biotech company (IPO in 1980 thanks notably to its groundbreaking synthetic insulin).

PREVIOUS EPISODES

bookmark
plus icon
share episode
episode art

Deep Tech Startups vs Covid-19 with Khosla Ventures, Fifty Years and SOSV

Deep Tech: From Lab to Market with Benjamin Joffe

play

06/08/20 • 45 min

This is a a live panel ran by SOSV to introduce and discuss solutions funded by some of the most active investors in deep tech startups fighting Covid-19.

This podcast is hosted by Benjamin Joffe, Partner at SOSV, a global early stage fund focused on deep tech with over $700m under management. SOSV runs multiple accelerator programs, including HAX (intelligent hardware) and IndieBio (life sciences).

Episode Overview

This recording has 3 parts:

  • Part 1: Some non-biotech solutions, from 3D printing to robotics,
  • Part 2, VCs present solutions from their portfolio (mostly biotech),
  • Part 3: Q&A.

The speakers are:

Introduction & Moderation:

Part 1

Introduction by Benjamin Joffe, Partner at SOSV

a. What has changed since SARS?

SARS was in 2003. In the span of 17 years, several important developments happened:

  • Low-cost genetic tests
  • Sensors & robots
  • Cloud solutions

The challenge of current solutions remain costs, timing and scalability.

b. Prevention

A hundred years ago, prevention was mostly... masks.

Today, we have a much better understanding of the modes of infection of viruses, and many new tools to prevent it.

c. 3D Printing

While we’re still far from the ‘3D printing revolution’ that was announced 10 years ago, some high-resolution 3D printing technology is able to supply useful parts quickly, at low cost, and on-site.

Clips and buckles for masks or door handles but also test swabs.

d. Protecting our face

We need to protect our face from others, but also from ourselves:

  • Many masks don’t effectively protect against infection as the virus is too small (about 120nm). Verdex (a SOSV portfolio company) has developed a nanofiber material that filters out particles above 100nm — effectively blocking the virus — and is also more breathable.
  • HabitAware, a HAX portfolio company, had created a machine-learning-powered bracelet to prevent body-focused repetitive behaviors (e.g. nail biting) by recognizing and alerting of specific gestures. The pandemic provided a new direct application of their technology
bookmark
plus icon
share episode
episode art
play

06/03/20 • 36 min

Eric Rosenblum is a Managing Partner at Tsingyuan Ventures, an early stage US fund with over $100m under management. They believe in the opportunity of cross-border and cross-discipline investments and focus primarily on US-based science startups founded by the Chinese tech diaspora.

  • Prior to co-founding Tsingyuan Ventures, Eric graduated from Harvard, worked at BCG then got an MBA at MIT and worked as a management consultant and serial entrepreneur in China for 14 years.
  • Eric was one of the rare foreign co-founders of multiple tech startups during China’s early Internet wave, and his ventures led to 2 exits (M&As for ChinaNOW and SmartPay).
  • Coming back to the states, he then worked at Google and Palantir before co-founding Tsingyuan Ventures with former members of the TEEC Angel Fund.
  • TEEC started as a network of Tsinghua University alumni (Tsinghua Entrepreneur & Executive Club (Tsinghua is like the MIT + Harvard of China) and wrote the first checks in 5 unicorns: Ginkgo Bioworks, Carta, Quanergy, Plus.ai, Zoom, and about 160 tech startups.
  • While it is a US fund, the Tsingyuan name reflects its focus and strategy by combining part of the Tsinghua (清) name and ‘source/origin’ (源).

Some context

This episode is particularly timely following the recent ‘Proclamation on the Suspension of Entry as Nonimmigrants of Certain Students and Researchers from the People’s Republic of China’ by the White House.

According to the Department of Homeland Security, in the 2018–19 academic year, there were enrolled at U.S. universities:

  • 272,470 undergraduate and graduate students from China.
  • 84,480 were in a graduate-level STEM program.

These restrictions are focused on students coming from mainland universities associated with the army, but might impact the ‘intellectual balance of trade’ that had been so favorable to the US so far.

Episode Overview

In this episode, we discuss:

  • The early days of China’s tech scene and the waves of Chinese PhDs in the US, to highlight the upcoming surge in opportunities, particularly with the many applications of AI at scale.
  • The intellectual balance of trade, and the value of this asset for the US.
  • The role of non-state actors like Google, Baidu or Alibaba as talent factories .
  • The 10-year lag between the moment a foreign student comes for a few years and starts a company, and why he believes we’re still just seeing the upswing of the wave.
  • China’s advances with regulation, local support and public acceptance of technology for the new wave of data-driven startups.
  • Analogies with basketball and pingpong to compare the impact and legacy of drafting outstanding talent into a system, and the risks of making the talent trade balance less favorable to America.
  • How cross-border talent will be key to create more truly global champions from the US.

References Mentioned

  • Eric mentions successful companies founded by the Chinese diaspora (including Guitar Hero, Nvidia, Zoom, etc.) More here.
  • In addition to cross-border, Eric makes the case for cross-disciplinary investments here.

Last, here are Eric's all-time favorites, that also happen to be very timely:

bookmark
plus icon
share episode
episode art
play

05/19/20 • 59 min

Leslie Jump is the CEO and Mack Kolarich the CPO of Different, an organization that helps institutions and family offices discover, analyze, diligence, and select venture capital funds.

  • They recently completed a remarkable DeepTech Investing Report based on more than 150 interviews with VCs, LPs and other stakeholders.
  • The report was funded by Schmidt Futures, a philanthropic vehicle created by former Google & Alphabet Chairman Eric Schmidt and his wife Wendy to “advance society through technology, inspire breakthroughs in scientific knowledge, and promote shared prosperity”.

Prior to Different, Leslie and Mack had diverse experiences including founding and investing in tech companies, and running investment workshops around the world.

This podcast is hosted by Benjamin Joffe, Partner at SOSV, a global early stage fund focused on deep tech. SOSV runs multiple accelerator programs including HAX (intelligent hardware) and IndieBio (life sciences).

Episode Overview

In a recent podcast with Joe Rogan, Elon Musk said:

"There’s an over allocation of talent in finance and law. We should have fewer people doing law and fewer people doing finance and more people making stuff. [...] If you don’t make stuff, there’s no stuff."

This seems especially true in deep tech.

In this episode, we discuss:

  • How scientific entrepreneurs are under-capitalized relative to the market and relative to their own potential.
  • What are the causes of this capital gap.
  • How media and others have trained VCs and LPs to look for, and expect unicorns, outliers and outsized multiples.
  • The optics problem of science vs. software startups with LPs and banks.
  • How most deep tech funds partners don’t have PhDs, but rely on networks on experts.
  • How — since when asked about a startup potential, 3 PhDs will give you 3 different answers — the job of investors is to figure out which one to believe.
  • How talent is spread out geographically more than we might expect, and how deep tech startups do not only come from universities.
  • The challenge of training or complementing scientists with business skills , particularly in ecosystems without a critical mass of business talent.
  • How LPs suffer from network bias when picking VC funds, and why only a minority is able to vest new deep tech funds, thinking ‘I don’t know how to know if they know what they’re doing’.
  • Why, within the ‘alternative assets ’ class, deep tech funds combine the highest risk, highest fees, longest terms, but also how delivering superior returns require new approaches , and how Covid-19 demonstrates that we need deep tech more than ever.
  • How deep tech startups differ from FMCG or SaaS companies, and why investors might have to custom-design KPIs for each company.
  • How looking outside of tech helps think differently about tech.

References Mentioned

Subscribe

  • Podcast:
bookmark
plus icon
share episode
episode art

Sota Nagano, Partner at Abies Ventures, on Japan's Deep Tech Scene

Deep Tech: From Lab to Market with Benjamin Joffe

play

05/12/20 • 23 min

Sota Nagano is a Partner at Abies Ventures, a $40m early stage deep tech fund based in Tokyo backed by Taizo Son, a billionare active tech investor, and younger brother of Masa, creator of the famous Vision Fund.

  • Abies Ventures invests in Japan and abroad in industrial tech,
  • But also opportunistically in multiple sectors including advanced sensors, space tech and life sciences.

Prior to Abies, Sota studied in the US and Italy, worked on Wall Street. He then co-founded an automotive engineering startup named GLM, which Financial Times called Japan’s Tesla, and which he took public for $1.5B in 2017.

This podcast is hosted by Benjamin Joffe, Partner at SOSV, a global early stage fund focused on deep tech with over $700m under management.

  • SOSV runs multiple accelerator programs, including HAX (intelligent hardware) and IndieBio (life sciences).
  • SOSV is also investing in Japan, via our hardware accelerator program HAX. We opened an office in Tokyo in 2019 with the support of Sumitomo, one of our key Japanese LPs.

Episode Overview

In this episode, we discuss:

  • Sota’s journey to deep tech investment,
  • The competitive advantages of Abies thanks to their broad industry network.
  • The most promising deep tech sectors in Japan and the opportunities for exits, notably with fast IPOs.
  • Finally, Sota shares his thought about the cost of failure in Japan, and the parallels he sees between Japan’s tech sector and the situation described in Ayn Rand’s Atlas Shrugged.

References Mentioned

  • Mistletoe: Taizo Son’s global investment vehicle for the startup ecosystem.
  • Euglena (Japan): $600m public company using ‘euglena’ (single cell flagellate eukaryotes) for food supplements, beauty care, biofuel and more. The stock peaked around $2 bln in 2013.
  • Cyberdyne (Japan): the ominous-sounding $500m public company makes futuristic exoskeletons. The stock peaked over $3 bln in 2016.
  • JAXA (Japan Aerospace Exploration Agency): Japan’s NASA.
  • Ultrasense Systems (USA): small ultrasound 3D sensors for next-generation UI.
  • Algal Bio (Japan): a biotech startup that uses thousands of strains of algae to produce functional nutrients, fatty acid, and carotenoids that have applications in food products, cosmetics, medicine, and fuel.
  • Pixie Dust (Japan): ultrasound array technology for control and interfaces, founded by Dr. Yoichi Ochiai (@ochyai on Twitter, with over 400k followers, on YouTube and video program on Newspicks, in Japanese). Raised $55.1 million.
  • Atlas Shrugged, by Ayn Rand
  • Layer Cake, starring pre-007 Daniel Craig as a cool-headed drug lord.

Subscribe

bookmark
plus icon
share episode

Show more

Toggle view more icon

FAQ

How many episodes does Deep Tech: From Lab to Market with Benjamin Joffe have?

Deep Tech: From Lab to Market with Benjamin Joffe currently has 17 episodes available.

What topics does Deep Tech: From Lab to Market with Benjamin Joffe cover?

The podcast is about Podcasts and Technology.

What is the most popular episode on Deep Tech: From Lab to Market with Benjamin Joffe?

The episode title 'The State and Opportunities In Robotics, with Fady Saad of MassRobotics' is the most popular.

What is the average episode length on Deep Tech: From Lab to Market with Benjamin Joffe?

The average episode length on Deep Tech: From Lab to Market with Benjamin Joffe is 39 minutes.

How often are episodes of Deep Tech: From Lab to Market with Benjamin Joffe released?

Episodes of Deep Tech: From Lab to Market with Benjamin Joffe are typically released every 10 days, 3 hours.

When was the first episode of Deep Tech: From Lab to Market with Benjamin Joffe?

The first episode of Deep Tech: From Lab to Market with Benjamin Joffe was released on Apr 2, 2020.

Show more FAQ

Toggle view more icon

Comments

0.0

out of 5

Star filled grey IconStar filled grey IconStar filled grey IconStar filled grey IconStar filled grey Icon
Star filled grey IconStar filled grey IconStar filled grey IconStar filled grey Icon
Star filled grey IconStar filled grey IconStar filled grey Icon
Star filled grey IconStar filled grey Icon
Star filled grey Icon

Rating

Star iconStar iconStar iconStar iconStar icon

Review or comment on this podcast...

Post

External Reviews

Imported reviews from Apple Podcasts.
















Generate a badge

Get a badge for your website that links back to this

Select type & size
Open dropdown icon
share badge image

Copy